Twinrix is a vaccine against hepatitis A and hepatitis B, manufactured by GlaxoSmithKline Biologicals. The full generic name is hepatitis A inactivated & hepatitis B (recombinant) vaccine. Twinrix is administered over three doses. The name was created because it is a mixture of two earlier vaccines — Havrix, an inactivated-virus Hepatitis A vaccine, and Engerix-B, a recombinant Hepatitis B vaccine. Twinrix first entered the market in early 1997.

Property Value
dbo:abstract
  • Twinrix is a vaccine against hepatitis A and hepatitis B, manufactured by GlaxoSmithKline Biologicals. The full generic name is hepatitis A inactivated & hepatitis B (recombinant) vaccine. Twinrix is administered over three doses. The name was created because it is a mixture of two earlier vaccines — Havrix, an inactivated-virus Hepatitis A vaccine, and Engerix-B, a recombinant Hepatitis B vaccine. Twinrix first entered the market in early 1997. In the United States, Twinrix is approved by the Food and Drug Administration (FDA) for those aged 18 and older. In some countries outside the United States, notably Canada and Europe, Twinrix is known as Twinrix Adult or Ambirix and a pediatric formulation, called Twinrix Junior or Twinrix Paediatric, is available. (en)
dbo:wikiPageEditLink
dbo:wikiPageExternalLink
dbo:wikiPageExtracted
  • 2019-09-23 05:40:13Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 6962050 (xsd:integer)
dbo:wikiPageLength
  • 7634 (xsd:integer)
dbo:wikiPageModified
  • 2019-09-23 05:40:04Z (xsd:date)
dbo:wikiPageOutDegree
  • 25 (xsd:integer)
dbo:wikiPageRevisionID
  • 917298879 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdfs:comment
  • Twinrix is a vaccine against hepatitis A and hepatitis B, manufactured by GlaxoSmithKline Biologicals. The full generic name is hepatitis A inactivated & hepatitis B (recombinant) vaccine. Twinrix is administered over three doses. The name was created because it is a mixture of two earlier vaccines — Havrix, an inactivated-virus Hepatitis A vaccine, and Engerix-B, a recombinant Hepatitis B vaccine. Twinrix first entered the market in early 1997. (en)
rdfs:label
  • Hepatitis A and B vaccine (en)
foaf:isPrimaryTopicOf
owl:sameAs
is foaf:primaryTopic of